Company Overview - The Honest Company was launched in 2012 with a focus on clean ingredients and sustainability[15] - The company's mission is to challenge ingredients, ideals, and industries to protect loved ones[16] - The Honest Standard includes banning over 3,500 ingredients and utilizing in-house labs for innovative formulas[18, 19] - The company is the 1 natural brand in baby personal care[20] and baby wipes[22] Financial Performance - In 2024, revenue reached $378 million, a 10% increase year-over-year[38] - Gross margin in 2024 was 38%, representing a 900 bps improvement year-over-year[38] - Adjusted EBITDA for 2024 was $26 million, a $37 million increase year-over-year[38] - The company had $75 million in cash and $0 debt at the end of 2024[29] - Q1 2025 revenue was $97 million, a 13% increase year-over-year[41] - Q2 2025 revenue was $93 million, a 0.4% increase year-over-year[44] Growth Strategy - The company is focused on brand maximization, margin enhancement, and operating discipline[28] - Household penetration has increased by 20% since 2021[24] - The company aims to expand distribution by increasing total distribution points[59] - There is a large runway for growth into more doors, with approximately 45,000 doors selling Honest products compared to a leading competitor's ~90,000 doors[66]

Financial Performance - Q2 2025 - Total company net sales reached $31.1 million, a 37% year-over-year increase[10] - Tru Niagen® net sales were $22.7 million, representing a 22% year-over-year increase[10] - Niagen® ingredient sales surged to $7.4 million, marking a 135% year-over-year increase[10] - Gross margin improved to 65.0%, up 480 basis points year-over-year[10] - Net income was $3.6 million, or $0.05 earnings per share, a $3.6 million year-over-year increase[10] - Adjusted EBITDA reached $5.0 million, a $3.5 million year-over-year increase[10] Financial Position - Cash provided from operations year-to-date was $9.1 million, with a cash balance of $60.5 million and no debt[10] Sales Mix - Q2 2025 - E-commerce accounted for 57% of net sales, while Watson's & Other B2B represented 25%[26] - Food-grade Niagen® contributed 14% to net sales, and Analytical Reference Standards & Services accounted for 3%[26] - Other Ingredients made up 1% of net sales[26] 2025 Outlook - The company anticipates net sales growth between 22% and 27% year-over-year[10] - Sales and marketing expenses are expected to increase in absolute dollars but decrease as a percentage of net sales year-over-year[10]

Financial Performance Highlights - Total billings grew by 15% year-over-year, reaching $1.778 billion in Q2 2025 [5, 21] - Unified SASE billings experienced significant growth of 21% year-over-year [5, 21] - SecOps billings also showed strong growth, increasing by 31% year-over-year [5, 21] - Total revenue increased by 14% year-over-year, reaching $1.630 billion in Q2 2025 [5, 31] - The company achieved a non-GAAP operating margin of 33% [5] - Unified SASE ARR (Annual Recurring Revenue) grew by 22% year-over-year, reaching $1.150 billion in Q2 2025 [26] - SecOps ARR grew by 35% year-over-year, reaching $463 million in Q2 2025 [27] - Adjusted Free Cash Flow reached $428 million [42] Product and Service Performance - Product revenue grew by 13% year-over-year [31] - Service revenue grew by 14% year-over-year [31] - The company shipped >50% of market global firewall units [7] Guidance - The company expects full year 2025 billings to be between $7.325 billion and $7.475 billion [47]

Financial Performance & Guidance - Q2 2025 total revenue reached $761 million, a 19% year-over-year increase[22] - Subscription revenue accounted for $745 million, reflecting a 19% year-over-year growth[22] - The company's Q3 2025 total revenue is projected to be between $785 million and $787 million, representing a 17% year-over-year increase[24] - Full year 2025 total revenue is guided to be between $3.080 billion and $3.088 billion, a 17% year-over-year increase[27] - Q2 2025 operating profit was $129 million, with an operating profit margin of 17%[22] - The company anticipates a full year 2025 operating profit between $568 million and $572 million, resulting in an 18% operating profit margin[27] - Free cash flow for Q2 2025 was $116 million[22] Growth & Market Opportunity - The company is targeting a long-term operating profit margin of 25%[43] - The company estimates its total addressable market (TAM) to be over $100 billion[18] - The company's platform has a penetration rate of less than 10% across all products, indicating significant growth potential[19] Ecosystem & Platform - The company's app marketplace has over 1700 integrations, a 10x increase over the last 5 years[15]

Financial Performance Highlights - Aggregate Subscriber Value reached $1.6 billion in 2Q25, a 40% year-over-year increase[7] - Contracted Net Value Creation was $376 million in 2Q25, up 316% year-over-year[7] - Cash Generation was $27 million in 2Q25, marking the fifth consecutive quarter of positive cash generation[8] - Upfront Net Subscriber Value exceeded $5.7k, representing an 11% margin, expanding 17 percentage points year-over-year[10] Operational Achievements - Customer Additions grew 15% year-over-year in Q2[14] - Customer Additions with Storage grew 50% year-over-year in Q2, with Storage Attachment Rate reaching 70%[14] - Sunrun dispatched 325 MWs of capacity during peak demand in California dispatches in June 2025[20] - Customer enrollments in home-to-grid distributed power plant programs has grown >300% y/y to more than 71k customers[17] Guidance and Outlook - 3Q 2025 Aggregate Subscriber Value is guided to be $1.5 to $1.6 billion, representing 8% growth year-over-year at the midpoint[81] - Full-year 2025 Contracted Net Value Creation is projected to be $1.0 to $1.3 billion, an increase from the prior guidance of $650 to $850 million, representing 67% growth year-over-year at the midpoint[81]

Financial Performance - Energy Transfer's Q2 2025 Adjusted EBITDA was $3.87 billion[7] - Distributable Cash Flow attributable to partners in Q2 2025 was $1.96 billion[7] - Year-to-date 2025 Growth Capital Expenditures reached $2.0 billion, while Maintenance Capital Expenditures were $418 million[7] - The company anticipates approximately $5.0 billion in Growth Capital Expenditures for the full year 2025[7] - The quarterly cash distribution increased to $0.33 per unit, a rise of over 3% compared to Q2 2024[7] Operational Highlights - Interstate natural gas transportation volumes increased by 11% compared to Q2 2024[7] - Midstream gathered volumes rose by 10%, setting a new partnership record[7] - Crude oil transportation volumes increased by 9%, also setting a new partnership record[7] - Total NGL exports increased by 5%, establishing another new partnership record[7] Strategic Initiatives - The company announced a 1.5 Bcf/d expansion to the Transwestern Pipeline, named the Desert Southwest expansion project, involving a 516-mile, 42-inch natural gas pipeline connecting the Permian Basin with markets in Arizona and New Mexico[7]

Company Overview - Tandem Diabetes Care has approximately 480,000 in-warranty customers across 25 countries[5, 81] - The company employs around 2,600 individuals worldwide and is headquartered in San Diego[5, 81] - Tandem offers two pump platforms: t:slim X2 and Tandem Mobi, both featuring Control-IQ+ Technology and cleared for type 1 and type 2 diabetes, with multiple CGM sensor integrations[7, 83] Product Portfolio - The Tandem Mobi system is 55% smaller than other insulin pumps and offers on-body wear options[17, 18] - 95% satisfaction rate among Tandem Mobi Early Access Participants[16] - The t:slim X2 insulin pump is the first in the United States to integrate with three continuous glucose monitoring sensors[22] Market and Growth - Less than 40% of the approximately 2 million people with type 1 diabetes in the U S use an insulin pump[55] - Less than 20% of the approximately 3 million people with type 1 diabetes in the countries Tandem serves use a pump[55] - Approximately 5% of the greater than 2 million people living with type 2 Insulin Intensive Diabetes in the U S use an insulin pump[55] - The company estimates 2025 GAAP Sales guidance of $1 billion[58]

Q3F25 Financial Performance - Revenue for Q3F25 was $148.4 million, a decrease of 8.4% quarter-over-quarter [9, 16] - Net loss for Q3F25 was $(3.3) million, while non-GAAP net income was $3.8 million [9] - EPS was $(0.06), and non-GAAP EPS was $0.07 [9] - Gross margin was 46.7%, an increase of 2180 bps quarter-over-quarter [18] - Operating expenses were $75.3 million, a decrease of $(49.7) million quarter-over-quarter [18] Outlook for Q4F25 - The company anticipates revenue of $170 million, with a potential variance of +/- $10 million [21] - The company expects operating expenses of $68.0 million, with a potential variance of +/- 2% [21] - The company projects diluted EPS of $0.22, with a potential variance of +/- 10% [21] Strategic Focus and Market Dynamics - The company is internally focused on efficiency, customer engagement, and new product execution [11] - Macro order hesitation, primarily affecting Auto/Industrial demand, contributed to the sequential revenue change [11] - Technology and capacity-related order activity are driving General Semi & Memory recovery [11] - Vertical Wire is positioned well for mobile-HBM, and new Wedge solutions are enabling more capable & efficient Power-Semi [11]

Financial Performance - e.l.f. Cosmetics' Q1 FY 2026 net sales increased by 9% year-over-year[14, 205] - The company achieved adjusted EBITDA growth of 12%[17] - e.l.f. Cosmetics has experienced 26 consecutive quarters of net sales growth and market share gains[21] - Adjusted net income for Q1 FY 2026 was $51 million, compared to $64 million in Q1 FY 2025[252] - Adjusted EPS for Q1 FY 2026 was $0.89, compared to $1.10 in Q1 FY 2025[253] Market Position and Growth Strategy - e.l.f. Cosmetics aims to double its net sales to $3 billion, with growth expected in cosmetics, skincare, and international markets[33] - The company has increased its unit share in the cosmetics category from approximately 7% in 2022 to around 15% today[43, 44] - e.l.f. Cosmetics is the 1 cosmetics brand at Target, holding a 21% dollar share[62] International Expansion - International net sales grew by 30% in Q1 FY 2026 year-over-year[135] - International penetration increased from 10% in FY 2020 to 20% in Q1 FY 2026[164] Tariffs - Tariffs are expected to have an annualized cost of goods sold (COGS) impact of $50 million[295, 298]

Financial Performance - Consolidated revenue decreased by 1% from $818 million in 2Q24 to $809 million in 2Q25[9] - Consolidated AEBITDA increased by 7% year-over-year, from $330 million in 2Q24 to $352 million in 2Q25[9] - Adjusted NPATA increased by 4% year-over-year, from $130 million in 2Q24 to $135 million in 2Q25[9] - iGaming AEBITDA increased by 17% year-over-year[17] - SciPlay AEBITDA increased by 6% year-over-year[17] Gaming Segment - Gaming revenue was $528 million in 2Q25, a decrease of 2% compared to $539 million in 2Q24[24] - Gaming operations revenue increased by 19% year-over-year, driven by the addition of Grover and growth in the North American installed base[26] - Gaming machine sales decreased by 16% year-over-year due to global macroeconomic uncertainty and timing of hardware refresh cycle in Australia[26] - North American installed base increased by 42% year-over-year to over 46,300 units[32] SciPlay Segment - SciPlay revenue was $200 million in 2Q25, a decrease of 2% compared to $205 million in 2Q24[37] - SciPlay's direct-to-consumer (DTC) platform generated $35 million, representing 18% of total SciPlay revenue[40] - Average Revenue Per Daily Active User (ARPDAU) grew 4% year-over-year to a record $1.08[40] iGaming Segment - iGaming revenue reached a record $81 million in 2Q25, a 9% increase compared to $74 million in 2Q24[46] - Wagers processed through OGS increased by 22% to $26.6 billion[47]